Senior insider sale
VIKING THERAPEUTICS, INC. — senior position signals high conviction
$2.13M
60K shares
What this filing means
ROWLAND CHARLES A JR plans to sell 60K shares of VIKING THERAPEUTICS, INC. valued at approximately $2.13M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/27/2025ACC: 0001950047-25-008201
Director
Since Jan 2019
60K
Shares to sell
$2.13M
Approx. market value
60K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Exercise of options under a registered plan
Cash
10/27/2025
22KExercise of options under a registered plan
Cash
10/27/2025
22KExercise of options under a registered plan
Cash
10/27/2025
16KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/27/2025 | Exercise of options under a registered plan Cash | 22K | — |
10/27/2025 | Exercise of options under a registered plan Cash | 22K | — |
10/27/2025 | Exercise of options under a registered plan Cash | 16K | — |
| Total | 60K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
60K
Market value
$2.13M
10/27/2025
Total
Units
60K
Value
$2.13M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/27/2025 | 60K | $2.13M | NASDAQ | Planned |
| Total | 60K | $2.13M | ||